PHI with Arteriosclerotic nephritis
How does this condition affect your private health insurance?
Arteriosclerotic nephritis, also known as benign nephrosclerosis, is a chronic kidney disease resulting from long-standing hypertension and atherosclerosis affecting the renal arterioles. This leads to hardening and narrowing of small arteries within the kidneys, impairing blood flow and causing ischemic damage to glomeruli and tubules. Over time, this progressive process leads to scarring, functional decline, and eventually chronic kidney disease. Symptoms often appear late and can include proteinuria, hypertension, and reduced kidney function, potentially progressing to end-stage renal disease. Early diagnosis and rigorous blood pressure control are crucial to slow its progression and manage complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Years, often insidious and asymptomatic initially, with subtle signs like proteinuria or mild creatinine elevation appearing gradually.
Duration of Illness (Lifetime)
Chronic, progressive disease spanning decades, requiring lifelong management.
Cost of Treatment (Initial)
Moderate (diagnostic tests, initial medication for hypertension management and kidney protection).
Cost of Treatment (Lifetime)
High (lifelong medication, regular monitoring, specialist consultations; extremely high if progression to end-stage renal disease requiring dialysis or transplantation).
Mortality Rate
Moderate to High (death usually results from associated cardiovascular complications like heart attack or stroke, or from end-stage renal disease if untreated or poorly managed).
Risk of Secondary Damages
High (cardiovascular disease, stroke, heart failure, fluid overload, anemia, electrolyte imbalances, bone disease, and progression to end-stage renal disease requiring dialysis or transplantation).
Probability of Full Recovery
Very low (it is a chronic, progressive disease; management focuses on slowing progression and managing symptoms rather than complete recovery).
Underlying Disease Risk
Very high (primarily chronic hypertension and generalized atherosclerosis are causative; often co-exists with diabetes mellitus and other cardiovascular risk factors).